Dataset Viewer
Auto-converted to Parquet
summarized
stringlengths
41
385
Hodgkin lymphoma first lymphomas recognized specific disease entity . Recent studies highlighted heterogeneity diseases associated eponym warranting clarification .
Chimeric antigen receptor (CAR) T-cell therapies demonstrated efficacy relapsed/refractory large B-cell lymphoma (LBCL) associated cytokine release syndrome (CRS) neurological events (NE) We wanted
A 56-year-old woman diagnosis diffuse large B-cell lymphoma dyspnea, weakness left upper extremity vocal cord paralysis . She underwent cervical, thoracal lumbosacral magnetic resonance imaging (MRI) However
Primary cardiac lymphoma (PCL) extremely rare fatal fatal heart neoplasm . Primary cardiac non-Hodgkin lymphoma (NHL) uncommon, considering rarity pericardial diffuse large B-cell lymphoma (
C-MYC expression immunohistochemical stain (IHC) shown independent prognostic factor DLBCL . In clinical setting, MYC stain currently evaluated manual quantification minimum positivity cut-off 40% .
Human immunodeficiency virus (HIV) infected patient caused patient suffer Garcin syndrome . In study, report parapharyngeal diffuse large B-cell lymphoma human immunodeficiency virus (HIV) infected patient caused
Chronic lymphocytic leukemia (CLL) experience histological transformation aggressive lymphoma called "Richter's transformation" This transformation usually leads diffuse large B cell lymphoma, though cases T cell lymphoma identified .
115 DLBCL patients admitted hospital treatment June 2020 June 2021 . 115 DLBCL patients admitted hospital treatment June 2020 June 2021 . 65 healthy subjects received physical examination hospital period selected healthy control group .
Primary mediastinal B-cell lymphoma (PMBCL) rare type diffuse large B-cell lymphoma . PMBCL typically presents large, fast-growing tumor limited mediastinum . R-CHOP commonly used
Tumour cells develop accumulating changes genome result changes main cellular processes . Aberrations basic processes replication chromatin reassembly particularly important genomic (in)stability .
The main function cartilage oligomeric matrix protein (COMP) maintain synthesis stability extracellular matrix interacting collagen . At present, relatively studies role protein tumors . This study aimed explore relationship COMP pan-cancer, analyzed diagnostic prognostic
Follicular lymphoma (FL) generally indolent B cell lymphoproliferative disorder transformed follicular center B cells . FL characterized diffuse lymphadenopathy, bone marrow involvement, splenomegaly. Cytopen
We report case middle-aged man unusual case bullous lichen sclerosus complicated morphea . He showed initial recurrent flaccid bullae, followed ivory-white sclerotic plaques extensive skin sclerosis, additional walking disorder
Meta-analysis research explored findings previous studies highlighted efficacy of HD and/or IT CNS prophylaxis in DLBCL patients intermediate high risk . Aim is to answer following research questions: (1) Is difference CNS relaps rel
Isatuximab (Isa, anti-CD38 antibody) combination cemiplimab (Cemi) combination cemiplimab (Cemi) isatuximab (Isa, anti-CD38 antibody
Circulating tumor DNA (ctDNA) become investigated analyte blood . It shed tumor circulation represents subset total cell-free DNA (cfDNA) pool released peripheral blood .
Direct comparisons effectiveness of novel therapies diffuse large B-cell lymphoma (DLBCL) treatment landscape range head-to-head randomized phase 3 trials would time-consuming costly . Comparative effectiveness studies using real-world data (R
Patients with diffuse large B-cell lymphoma (DLBCL) undergo HCT 2008 2020 . DLBCL underwent HCT 2008 2020 . DLBCL underwent HCT 2008 2020 . DLBCL underwent HCT 2008 2020 .
Febrile neutropenia risk prediction models important clinical practice, external validation limited .
61-year-old man presented three distinct tumors concurrently 2021: noninvasive urothelial carcinoma bladder, diffuse large B-cell lymphoma, squamous cell carcinoma lung . MPMs defined coexistence at least two
Epstein-Barr virus (EBV) considered carcinogenic virus, associated high risk poor prognosis lymphoma patients . We aimed identify immunological microenvironment molecular signatures lead poor prognosis EBV+ lymphoma patients . Differential genes
The incidence cardiac lymphoma is low, mainly occurs secondary non-Hodgkin's lymphoma, particularly diffuse large B-cell lymphoma .
Macrophage-capping protein (CAPG) discovered play crucial part regulator various cancers . It still remains unclear regarding regulatory mechanism of DLBCL .
Diffuse large B-cell lymphoma (DLBCL) common aggressive non-Hodgkin lymphoma, 10% DLBCL cases primarily occur gastrointestinal tract . Primary gastrointestinal-DLBCL (pGI-DLBC
RNA expression profiling using next-generation sequencing provides reliable reproducible information biology cancer . RNA expression profiling using next-generation sequencing provides reliable reproducible information biology cancer .
Primary adrenal lymphoma (PAL) extremely rare entity, cases reported . Symptoms atypical, making difficult obtain accurate early diagnosis .
We investigated clinicopathologic features 5 follicular lymphomas (FL) transformed morphologic diffuse large B-cell lymphomas (DLBCL) primary mediastinal large B-cell lymphoma (PMBL) lymphoma (PM
WHO classification haematolymphoid tumours worldwide accepted reference malignant tumours myeloid lymphoid system . The REAL classification 1994 laid foundations WHO volumes, continous development specification date [3, 5, 6]. In 5
Metal ions play role pathogenesis lymphoma . Metal ions play role pathogenesis lymphoma .
High-dose methotrexate (HD-MTX) standard therapy primary central nervous system lymphoma (PCNSL) prognosis remains poor . Because 90% PCNSL diffuse large B-cell lymphoma (DLBC
We present case older male adult adult adult adult primary spinal diffuse large B-cell lymphoma (DLBCL) presenting spinal cord compression treated surgery followed high dose methotrexate combination RCHOP .
Recent reports suggest aggressive non-Hodgkin lymphomas might benefit concomitantly receiving statins rituximab, cyclophosphamide, hydroxydaunorubicin, vincristine (On
PSENHLs diffuse large B-cell lymphomas commonly caused chronic inflammatory process, chronic infection, autoimmune disease . The majority PSENHLs diffuse large B-cell lymphomas are commonly caused chronic inflammatory process, chronic infection, autoimmune
Diffuse large B cell lymphoma (DLBCL) aggressive subtype non-Hodgkin lymphoma accounts third NHL cases . A significant proportion of treated DLBCL patients develop refractory relapsed disease due drug resistance
Intravascular large B-cell lymphoma (IVLBCL) uncommon lymphoma aggressive clinical course characterized selective growth tumor cells within vessels . Pathogenesis still uncertain little information underlying genomic alterations .
Diffuse large B cell lymphoma (DLBCL) involve almost organ, prognosis patients DLBCL different primary sites varies greatly . 5-Hydroxymethylcytosine (5hmC) plays vital role tumor
CAR-T cell therapy approved patients with leukemia diffuse large B-cell lymphoma . Its use subsequent toxicities expected rise coming years . Cytokine release syndrome observed 40% patients .
Single-centre study aimed determine clinicopathological characteristics prognosis patients co-existing FL DLBCL components (FL/DLBCL) Among 56 FL/DLBCL cases analysed, 67.9% germinal centre
The subclassification of diffuse large B-cell lymphoma (DLBCL) germinal center B-cell-like (GCB) activated B-cell-like (GCB) activated B-cell-like (ABC
Diffuse large B-cell lymphoma (DLBCL) common type B-cell lymphoma . Multilobated subtype DLBCL observed since 1970s, little known clinical significance unique variant era rituximab
Antiretroviral therapy may alter susceptibility nonkeratinocyte skin cancers (NKSCs) improving immunity people living HIV (PLWH) Using linked data HIV cancer registries 12 US states/regions ART era (1996-
circulating tumor DNA (ctDNA) has been developed to detect lymphoma sensitively tumor-derived DNA . This article discusses various methods ctDNA detection clinical context applied variety lymphoma subtypes .
Diffuse large B cell lymphoma (DLBCL) common pathological subtype non-Hodgkin lymphoma (NHL) common type adult lymphoma . New drug targets therapeutic methods urgently needed .
64-year-old man underwent liver transplantation, presented chest pain exertional dyspnea, developed huge cardiac mass within 2 months passed away day 3 hospitalization . Histological examination revealed diffuse large B-cell lymphoma (DL
19-year-old man diagnosed with large B-cell lymphoma undergoing chemotherapy presented recurrent emesis weight loss . Endoscopic ultrasound-guided gastroenterostomy using lumen-apposing metal stent performed bypass obstruction . Subsequently
Patients cartilage-hair hypoplasia (CHH) increased risk of non-Hodgkin lymphoma basal cell carcinoma . Lymphoma diagnosis remains unexplored, but clinical course, response therapy outcome lymphomas CHH
Primary human herpesvirus 8 (HHV8)-unrelated effusion large B-cell lymphoma (ELBCL) recognized new clinical entity . Pathogenesis therapeutic strategies remain largely unknown .
PD-L1 human lymphomas were analyzed using hyperspectral imaging (HSI) and fluorescent multiplex immunohistochemistry (mIHC) We analyzed expression PD-L1 human lymphomas using hyperspectral imaging (
Patients angioimmunoblastic T-cell lymphoma (AITL) treated cyclophosphamide, doxorubicin, vincristine prednisone without etoposide (CHO(E)
Gene expression involved B lymphocyte differentiation maturation within germinal center (GC) regulated epigenetically lymphomas . Episodes play critical roles pathogenesis of GC-driven lymphomas .
Given mixed evidence carcinogenicity current-use herbicides, studied relationship occupational herbicide use risk non-Hodgkin's lymphoma (NHL) NHL is a large, pooled study of 10 case-control studies .
Adaptor protein transducin β-like 1 (TBL1X) homolog TBL1XR1 shown upregulated solid tumors hematologic malignancies, overexpression associated poor clinical outcomes . Dysregulation T
Diffuse large B-cell lymphoma (DLBCL) common non-Hodgkin lymphoma around world . R-CHOP significantly improved patient outcomes, subset patients still poor outcome .
Splenocolic fistula extremely rare condition described literature . A fistula connects bowel organs, urinary bladder small intestine, small intestine . It occurs cases splenic tumors, including splenic diffuse large B cell lymphoma .
Despite mounting evidence causal role increasing number lymphoma subtypes, studies systematically tested entire spectrum Hodgkin non-Hodgkin lymphomas presence Epstein-Barr virus (EBV) Here, describe prevalence EBV large, unselected
Coronavirus disease 2019 (COVID-19) spread worldwide . Vaccination recommended one effective countermeasures control pandemic prevent worsening symptoms . However, adverse effects attracting attention .
This subtype CNS lymphoma diffuse large B-cell Epstein-Barr virus-positive . Its accurate presurgical diagnosis often unfeasible appears ring-enhancing lesions mimicking glioblastoma metastasis .
Dogs diffuse large B-cell lymphoma (DLBCL) diagnosed with diffuse large B-cell lymphoma (DLBCL) diagnosed with inferior survival times . Specific biomarkers inflammation identified prognostic indicators dogs DLBCL .
Burkitt lymphoma accounts majority pediatric non-Hodgkin lymphomas less common significantly lethal diagnosed adults . We sought to identify somatic changes underlie lymphomagenesis aBL molecular features associate clinical disparities within pBL aBL
POLARIX study shown improvement standard backbone rituximab plus cyclophosphamide, doxorubicin, vincristine, prednisone frontline setting . In relapsed refractory setting, two unique
PLD epirubicin (PLD) dose intensity survival outcomes . The study showed PLD epirubicin similar efficacy (overall survival (OS) p = 0.776; progressio .
Double-expressor lymphoma (DEL) associated poor prognosis . R-CHOP DA-EPOCH-R first-line therapy patients DEL urgently needed .
Ocular adnexal lymphoma relatively rare disease one common malignancies ocular adnexa, incidence steadily increasing . Ocular adnexal lymphoma consists mainly four histopathological subtypes non-Hodgkin B
We report establishment novel activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) cell line . TMD12 cells isolated pleural effusion patient relapse passaged continuously vitro >4 years .
Clonality assays antigen receptor rearrangement used adjunct examinations lymphoproliferative diseases . Canine diffuse large B cell lymphomas (DLBCL), cutaneous pla, cutaneous pla, and diffuse large B
Primary adrenal lymphoma (PAL) aggressive form lymphoma associated adrenal insufficiency (AI) cases . It requires histologic confirmation unlike cases primary AI .
Primary orbital lymphoma accounts essential part adult orbital malignancies . It accounts for <1% non-Hodgkin's lymphoma cases . Orbital diffuse large B-cell lymphoma (DLBCL) one prevalent subtype
Diffuse large B-cell lymphoma (DLBCL) common subtype adult lymphomas . Patients often difficulty tolerating standard chemotherapy regimens due comorbidities .
Chinese patients follicular lymphoma (FL) limited. Here, conducted retrospective study explore initial treatment strategies . Chinese patients newly diagnosed Tianjin Medical University Cancer Institute Hospital March 2002 August 2020. A total 926 FL patients enrolled. The median
Inhibitors targeting Bruton's tyrosine kinase (BTK) revolutionized treatment various B-cell malignancies .
PD-1/PD-L1 pathway pathway played role in PD-1/PD-L1 pathway . Thirty-four cases (64.2%) showed high expression PD-L1 .
Previous studies shown diffuse large B-cell lymphoma (DLBCL) subtype B-cell antigen receptor complex-associated protein beta chain (CD79B) myeloid differentiation primary response 88 mutations (MYD88) inferior
56-year-old patient underwent tracheal sleeve pneumonectomy . Complex pulmonary aspergilloma invading almost entire right lung carina .
Elderly Prognostic Index (EPI) based integration simplified geriatric assessment, hemoglobin levels and hemoglobin levels . EPI validated predict overall survival of older patients with diffuse large B-cell lymphoma (DLBCL)
A 57-year-old male came hospital complaining abdominal pain complaining of abdominal pain . He underwent abdominal computed tomography contrast, showed full-thickness wall thickening ileocecal region . He underwent lower gastrointestinal endosc
The role of Helicobater pylori eradication treatment high-grade diffuse large B-cell lymphoma (DLBCL) is unclear . We performed systematic review meta-analysis of currently available data .
Cardiac lymphoma (CL) rare life-threatening clinical condition . Most cases diagnosed late period . Most cases diagnosed late period .
Diffuse large B-cell lymphoma (DLBCL) common type lymphoma worldwide, accounting 40% cases . IL-20 expressed frequently follicular lymphoma (94%) Burkitt lymphoma (81%) and mantle c lymph
Methotrexate-associated lymphoproliferative disorder (MTX-LPD) occur oral cavity, cases palatal involvement reported . Chemotherapy may needed remission withdrawal MTX .
Patients renal impairment (RI) typically excluded trials evaluating chimeric antigen receptor (CAR) T cell therapies . We evaluated outcomes patients receiving standard care (SOC) CAR T cell therapy relapsed/refractory (R/R)
We retrospectively reviewed renal pathology profiles January 2010 December 2021, 28 patients B-cell LPD combined intact renal biopsy data included . There 20 men eight women aging 41 79 years time renal biopsy (median age 62 years)
Core needle biopsies (CNB) may not meet increasing tissue requirements clinical trials . Core needle biopsies may not meet increasing tissue requirements . This potentially lead selective enrollment patients undergo excisional biopsy .
Relationship between Epstein-Barr virus-encoded small RNA (EBER) early treatment lymphoma remains unclear . We explored discrepancies PEDL variables associated with PEDL variables associated with PEDL variables . Median PEDL
Autologous stem cell transplantation (ASCT) chimeric antigen receptor (CAR) T-cells two therapeutic options relapsed/refractory diffuse large B-cell lymphoma . Both intensive potentially curative therapies differ efficacy toxicity
B-cell lymphoma 6 (BCL6) protooncogene adult pediatric cancers . First identified diffuse large B-cell lymphoma (DLBCL) acts repressor tumor suppressor TP53 . BCL6 expression normal
Lymphomas affecting sublingual glands extremely rare case reports currently available . Lymphomas affecting sublingual glands extremely rare case reports currently available . Aim current study describe clinicopathological features series lymphomas involving sublingual glands .
EFS24 established endpoint diffuse large B-cell lymphoma (DLBCL) follicular lymphoma (FL) role undefined MCL . To evaluate prognostic role EFS24 MCL.
Until recently, molecular bases disease subtypes unclear . Specific genetic characteristics distinguish subtypes respective systemic counterparts .
107 patients OL treated 14-year period Polish hematological centers . Median patient age 60 years (range 51-71) Median patient age 60 years (range 51-71) Median patient age 60 years (range 51-71)
Long non-coding RNAs (lncRNAs) confirmed connected tumor proliferation, apoptosis, metastasis recurrence . Previous studies indicated lncRNA calcium voltage-gated channel subunit α1 G (CACNA
Duodenal-type follicular lymphoma (D-FL) recognized rare entity accounts approximately 4% primary gastrointestinal lymphomas . D-FL follows indolent clinical course compared common nodal FL generally considered better prognosis .
Diffuse large B-cell lymphoma (DLBCL) heterogeneous disease existing prognosis systems based clinical variables difficult stratify patients accurately . Nutritional indices play meaningful role prognosis solid tumors, whereas effect DLBCL still equ
Central nervous system (CNS) lesions peripheral neuropathy rare among patients non-Hodgkin's lymphoma (NHL) Central nervous system (CNS) lesions peripheral neuropathy rare among patients non-Hodgkin
Diffusion large B cell lymphoma (DLBCL) developed range new treatment programs based characteristics disease, bringing us era immune-chemotherapy . However, effectiveness molecular mechanisms of targeted-immunotherapy remain unclear . Targeted-
59-year-old male enlargement treated with Burkitt-like lymphoma (BLL) Cytogenetics revealed absence of absence MYC rearrangement involving MYC rearrangement involving MYC rearrangement
Nail changes well-known phenomenon T-cell lymphoma reported widely B-cell lymphomas Hodgkin lymphomas .
Next-generation sequencing (NGS) elucidates diffuse large B-cell lymphoma (DLBCL) genetic characteristics . Study included 20 patients DLBCL.
Diffuse large B-cell lymphoma (DLBCL) common aggressive non-Hodgkin's lymphoma (NHL) accounting 30%-40% adult NHL . Primary testicular (PT) lymphoma uncommon extran
Diffuse large B-cell lymphoma (DLBCL) heterogeneous non-Hodgkin's lymphoma great clinical challenge . Machine learning (ML) attracted substantial attention diagnosis, prognosis, treatment diseases .
Primary pancreatic lymphoma rare; commonly described subtype diffuse large B-cell lymphoma . Although morphologically similar lymphoproliferative lesions found locations, clinically mimic epithelial neoplasm . The differential diagnosis important due due different
End of preview. Expand in Data Studio

No dataset card yet

Downloads last month
10